OBJECTIVE: Scavenger receptors play crucial roles in the pathogenesis of atherosclerosis, but their role in insulin resistance has not been explored. We hypothesized that scavenger receptors are present in human adipose tissue resident macrophages, and their gene expression is regulated by adiponectin and thaizolidinediones. METHODS AND RESULTS: The gene expression of scavenger receptors including scavenger receptor-A (SRA), CD36, and lectin-like oxidized LDL receptor-1 (LOX-1) were studied in subcutaneous adipose tissue of nondiabetic subjects and in vitro. Adipose tissue SRA expression was independently associated with insulin resistance. Pioglitazone downregulated SRA gene expression in adipose tissue of subjects with impaired glucose tolerance and decreased LOX-1 mRNA in vitro. Macrophage LOX-1 expression was decreased when macrophages were cocultured with adipocytes or when exposed to adipocyte conditioned medium. Adding adiponectin neutralizing antibody resulted in a 2-fold increase in LOX-1 gene expression demonstrating that adiponectin regulates LOX-1 expression. CONCLUSIONS: Adipose tissue scavenger receptors are strongly associated with insulin resistance. Pioglitazone and adiponectin regulate gene expression of SRA and LOX-1, and this may have clinical implications in arresting the untoward sequalae of insulin resistance and diabetes, including accelerated atherosclerosis.
RCT Entities:
OBJECTIVE: Scavenger receptors play crucial roles in the pathogenesis of atherosclerosis, but their role in insulin resistance has not been explored. We hypothesized that scavenger receptors are present in humanadipose tissue resident macrophages, and their gene expression is regulated by adiponectin and thaizolidinediones. METHODS AND RESULTS: The gene expression of scavenger receptors including scavenger receptor-A (SRA), CD36, and lectin-like oxidizedLDL receptor-1 (LOX-1) were studied in subcutaneous adipose tissue of nondiabetic subjects and in vitro. Adipose tissue SRA expression was independently associated with insulin resistance. Pioglitazone downregulated SRA gene expression in adipose tissue of subjects with impaired glucose tolerance and decreased LOX-1 mRNA in vitro. Macrophage LOX-1 expression was decreased when macrophages were cocultured with adipocytes or when exposed to adipocyte conditioned medium. Adding adiponectin neutralizing antibody resulted in a 2-fold increase in LOX-1 gene expression demonstrating that adiponectin regulates LOX-1 expression. CONCLUSIONS:Adipose tissue scavenger receptors are strongly associated with insulin resistance. Pioglitazone and adiponectin regulate gene expression of SRA and LOX-1, and this may have clinical implications in arresting the untoward sequalae of insulin resistance and diabetes, including accelerated atherosclerosis.
Authors: Neda Rasouli; Aiwei Yao-Borengasser; Leslie M Miles; Steven C Elbein; Philip A Kern Journal: Am J Physiol Endocrinol Metab Date: 2005-08-23 Impact factor: 4.310
Authors: Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin Journal: J Lipid Res Date: 2005-09-08 Impact factor: 5.922
Authors: Henning Morawietz; Sandra Erbs; Jürgen Holtz; Andreas Schubert; Michael Krekler; Winfried Goettsch; Oliver Kuss; Volker Adams; Karsten Lenk; Friedrich W Mohr; Gerhard Schuler; Rainer Hambrecht Journal: Circulation Date: 2006-07-04 Impact factor: 29.690
Authors: Angela M Bodles; Vijayalakshmi Varma; Aiwei Yao-Borengasser; Bounleut Phanavanh; Charlotte A Peterson; Robert E McGehee; Neda Rasouli; Martin Wabitsch; Philip A Kern Journal: J Lipid Res Date: 2006-06-23 Impact factor: 5.922
Authors: Michael Spencer; Aiwei Yao-Borengasser; Resat Unal; Neda Rasouli; Catherine M Gurley; Beibei Zhu; Charlotte A Peterson; Philip A Kern Journal: Am J Physiol Endocrinol Metab Date: 2010-09-14 Impact factor: 4.310
Authors: Min Ding; Ana Catarina Carrão; Robert J Wagner; Yi Xie; Yu Jin; Eva M Rzucidlo; Jun Yu; Wei Li; George Tellides; John Hwa; Tamar R Aprahamian; Kathleen A Martin Journal: J Mol Cell Cardiol Date: 2011-09-17 Impact factor: 5.000
Authors: Helen M Lawler; Chantal M Underkofler; Philip A Kern; Christopher Erickson; Brooke Bredbeck; Neda Rasouli Journal: J Clin Endocrinol Metab Date: 2016-02-12 Impact factor: 5.958
Authors: Jeanette M Metzger; Helen N Matsoff; Alexandra D Zinnen; Rachel A Fleddermann; Viktoriya Bondarenko; Heather A Simmons; Andres Mejia; Colleen F Moore; Marina E Emborg Journal: PLoS One Date: 2020-01-07 Impact factor: 3.240
Authors: Philip A Kern; Brian S Finlin; Beibei Zhu; Neda Rasouli; Robert E McGehee; Philip M Westgate; Esther E Dupont-Versteegden Journal: J Clin Endocrinol Metab Date: 2014-12 Impact factor: 5.958
Authors: Robert N Helsley; Yipeng Sui; Se-Hyung Park; Zun Liu; Richard G Lee; Beibei Zhu; Philip A Kern; Changcheng Zhou Journal: Stem Cells Date: 2016-03-28 Impact factor: 6.277